Voluntary Scheme for Branded Medicines Pricing and Access Archives -

Companies can choose whether or not to submit to NICE to have their products appraised. Many do, presumably

Time to ask companies why they don’t submit to NICE?

https://pharmaphorum.com/market-access-2/time-to-ask-companies-why-they-dont-submit-to-nice/

In the second part of this series taking stock of the 2019 Voluntary Scheme for Branded Medicines Pricing

VPAS: Achievements so far on affordability

https://pharmaphorum.com/views-analysis-market-access/vpas-achievements-so-far-on-affordability/

The UK has a voluntary agreement that was struck by the government and NHS England (now referred to

VPAS: Achievement so far on objectives for patients

https://pharmaphorum.com/views-analysis-market-access/vpas-achievement-so-far-on-objectives-for-patients/

Voluntary Scheme for Branded Medicines Pricing and Access